“Oh when's your treatment ending?” “Never!” The unmet needs of cancer patients treated with immunological, biological and precision therapies: A qualitative interview study
Patients with advanced cancer being treated with IBP therapies have a diverse range of often inter-related unmet needs. It is vital that healthcare professionals involved in the care of cancer patients using IBP therapies are alert to the unmet needs among this patient group. Interventions and services should be developed to address these needs.
Authors
- Andy Bojke
- Alastair Greystoke (ORCID: https://orcid.org/0000-0001-9168-0387)
- Jan Lecouturier (ORCID: https://orcid.org/0000-0002-5191-5804)
- Joshua E. Richardson (ORCID: https://orcid.org/0000-0003-3066-2673)
- Louise Carter (ORCID: https://orcid.org/0000-0002-9854-2304)
- Lisa Crowe (ORCID: https://orcid.org/0000-0002-9814-2124)
- Rona Bojke
- A. Todd
- Mary Wells (ORCID: https://orcid.org/0000-0001-5789-2773)
- Morven C. Brown (ORCID: https://orcid.org/0000-0003-2501-0670)
- L. Sharp
- Ezinne Ezeala
Institutions
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Newcastle University (GB)
Publication Details
- Journal
- European Journal of Oncology Nursing
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1016/j.ejon.2024.102696
- Citations
- 2
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.26